Establishment of a gnotobiotic pig model of Clostridioides difficile infection and disease.
Author
Nyblade, CharlotteParreno, Viviana
Zhou, Peng
Hensley, Casey
Oakes, Vanessa
Mahsoub, Hassan M
Kiley, Kelsey
Frazier, Maggie
Frazier, Annie
Zhang, Yongrong
Feng, Hanping
Yuan, Lijuan
Date
2022-06-06Journal
Gut PathogensPublisher
Springer NatureType
Article
Metadata
Show full item recordAbstract
Clostridioides difficile (C. difficile) is a gram-positive, spore-forming, anaerobic bacterium known to be the most common cause of hospital-acquired and antibiotic-associated diarrhea. C. difficile infection rates are on the rise worldwide and treatment options are limited, indicating a clear need for novel therapeutics. Gnotobiotic piglets are an excellent model to reproduce the acute pseudomembranous colitis (PMC) caused by C. difficile due to their physiological similarities to humans and high susceptibility to infection. Here, we established a gnotobiotic pig model of C. difficile infection and disease using a hypervirulent strain. C. difficile-infected pigs displayed classic signs of C. difficile infection, including severe diarrhea and weight loss. Inoculated pigs had severe gross and microscopic intestinal lesions. C. difficile infection caused an increase in pro-inflammatory cytokines in samples of serum, large intestinal contents, and pleural effusion. C. difficile spores and toxins were detected in the feces of inoculated animals as tested by anaerobic culture and cytotoxicity assays. Successful establishment of this model is key for future work as therapeutics can be evaluated in an environment that accurately mimics what happens in humans. The model is especially suitable for evaluating potential prophylactics and therapeutics, including vaccines and passive immune strategies.Data Availibility
All data are included in this manuscript.Rights/Terms
© 2022. The Author(s).Keyword
Clostridioides difficile infection/illness (CDI)Gnotobiotic pigs
Pseudomembranous colitis (PMC)
Identifier to cite or link to this item
http://hdl.handle.net/10713/19108ae974a485f413a2113503eed53cd6c53
10.1186/s13099-022-00496-y
Scopus Count
Collections
Related articles
- Genomic and Phenotypic Characterization of the Nontoxigenic Clostridioides difficile Strain CCUG37785 and Demonstration of Its Therapeutic Potential for the Prevention of C. difficile Infection.
- Authors: Wang S, Heuler J, Wickramage I, Sun X
- Issue date: 2022 Apr 27
- Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence.
- Authors: Castro-Córdova P, Díaz-Yáñez F, Muñoz-Miralles J, Gil F, Paredes-Sabja D
- Issue date: 2020 Apr
- Clostridioides difficile spores stimulate inflammatory cytokine responses and induce cytotoxicity in macrophages.
- Authors: Chiu PJ, Rathod J, Hong YP, Tsai PJ, Hung YP, Ko WC, Chen JW, Paredes-Sabja D, Huang IH
- Issue date: 2021 Aug
- Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil.
- Authors: Maestri AC, Raboni SM, Morales HMP, Ferrari LF, Tuon FFB, Losso A, Marconi C, Nogueira KDS
- Issue date: 2020 Aug
- An Aniline-Substituted Bile Salt Analog Protects both Mice and Hamsters from Multiple Clostridioides difficile Strains.
- Authors: Phan JR, Do DM, Truong MC, Ngo C, Phan JH, Sharma SK, Schilke A, Mefferd CC, Villarama JV, Lai D, Consul A, Hedlund BP, Firestine SM, Abel-Santos E
- Issue date: 2022 Jan 18